Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases

Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases

Tripterygium wilfordii Hook. f. (TwHF) is a Chinese botanical drug containing a large number of metabolites. The discovered and recognized anti-inflammatory and immune-regulating effects have made it attract more and more attentions in trials and clinical researches. The extraction and processing of...

Full description

Bibliographic Details
Main Authors:	Xue Tong, Yanheng Qiao, Yuanjian Yang, Haizhao Liu, Zhiyong Cao, Bo Yang, Lijuan Wei, Hongtao Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Pharmacology
Subjects:	tripterygium wilfordii hook. f. tripterygium wilfordii hook. f. preparations kidney diseases clinical applications mechanisms toxicity
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.846746/full

Similar Items

Efficacy and Safety of Tripterygium wilfordii Hook F Versus Acitretin in Moderate to Severe Psoriasis Vulgaris: A Randomized Clinical Trial
by: Chao Wu, et al.
Published: (2015-01-01)

The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review
by: Peng Liu, et al.
Published: (2021-09-01)

Adverse Events Associated With Treatment of Tripterygium wilfordii Hook F: A Quantitative Evidence Synthesis
by: Yi Ru, et al.
Published: (2019-11-01)

Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria
by: Yuanyuan Guo, et al.
Published: (2021-01-01)

Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study
by: Yang-zhong Zhou, et al.
Published: (2018-04-01)

Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis
by: Liu Liu, et al.
Published: (2018-08-01)

A novel strategy to enhance terpenoids production using cambial meristematic cells of Tripterygium wilfordii Hook. f.
by: Yadi Song, et al.
Published: (2019-11-01)

Tripterygium wilfordii Hook. F. and Its Extracts for Psoriasis: Efficacy and Mechanism
by: Wang Y, et al.
Published: (2023-12-01)

The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Ying-Yan Zhou, et al.
Published: (2018-04-01)

Safety profiles of Tripterygium wilfordii Hook F: a systematic review and meta-analysis
by: Chi Zhang, et al.
Published: (2016-11-01)

A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
by: Shao-Ru Chen, et al.
Published: (2018-02-01)

The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study
by: Yaqi Cheng, et al.
Published: (2024-12-01)

Tripterygium wilfordii Hook.f. ameliorates paraquat-induced lung injury by reducing oxidative stress and ferroptosis via Nrf2/HO-1 pathway
by: Cong-Ying Song, et al.
Published: (2023-03-01)

The Combination of Low-Temperature Plasma and <i>Tripterygium wilfordii Hook F</i> on Ameliorating Imiquimod-Induced Psoriasiform Dermatitis in Mice
by: Song Zhang, et al.
Published: (2021-12-01)

Qingluo Tongbi Formula Alleviates Hepatotoxicity Induced by Tripterygium wilfordii Hook. F. by Regulating Excessive Mitophagy Through the PERK-ATF4 Pathway
by: Linluo Zhang, et al.
Published: (2022-07-01)

Network pharmacology- and molecular docking-based approach for predicting key targets and the potential mechanism of Tripterygium wilfordii Hook F for the treatment of acute lymphoblastic leukaemia
by: Xi Li, et al.
Published: (2022-12-01)

A comprehensive review of Tripterygium wilfordii hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions
by: Yu Shan, et al.
Published: (2023-11-01)

Screening of major hepatotoxic components of Tripterygium wilfordii based on hepatotoxic injury patterns
by: Meng Li, et al.
Published: (2023-01-01)

Tripterygium Ingredients for Pathogenicity Cells in Rheumatoid Arthritis
by: Yujun Tang, et al.
Published: (2020-10-01)

Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
by: Hongyun Wang, et al.
Published: (2023-08-01)

New 18(4→3)-Abeo-Abietanoids from Tripterygium wilfordii
by: Lin Ni, et al.
Published: (2018-09-01)

Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking
by: Jing Zhang, et al.
Published: (2021-01-01)

The complete chloroplast genome of Tripterygium wilfordii Hook. f. (Celastraceae)
by: Yuan Zhong, et al.
Published: (2022-09-01)

A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn’s disease
by: Jing Zhang, et al.
Published: (2020-03-01)

Mechanism of Tripterygium wilfordii Hook.F.- Trichosanthes kirilowii Maxim decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking
by: Lingfei Lu, et al.
Published: (2022-10-01)

Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis
by: Yehui Li, et al.
Published: (2021-06-01)

Genome‐wide analysis of MYB family genes in Tripterygium wilfordii and their potential roles in terpenoid biosynthesis
by: Meng Xia, et al.
Published: (2022-07-01)

Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection
by: Hui-Fang Zhou, et al.
Published: (2005-04-01)

Immunosuppressive Sesquiterpene Pyridine Alkaloids from <i>Tripterygium wilfordii</i> Hook. f.
by: Yadan Wang, et al.
Published: (2022-10-01)

Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: A case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer
by: Xiaoyi Zhang, et al.
Published: (2022-10-01)

Synergetic HepG2 cells suppression efficacy of Tripterygium wilfordii and Scutellaria barbata through EGFR/PI3K/Akt pathway
by: Susu Liu, et al.
Published: (2022-09-01)

Mechanistic analysis for the origin of diverse diterpenes in Tripterygium wilfordii
by: Lichan Tu, et al.
Published: (2022-06-01)

Cloning and Characterisation of the Gene Encoding 3-Hydroxy-3-Methylglutaryl-CoA Synthase in Tripterygium wilfordii
by: Yu-Jia Liu, et al.
Published: (2014-11-01)

Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
by: Lin Wang, et al.
Published: (2021-06-01)

Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
by: Na Lin, et al.
Published: (2021-01-01)

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
by: Shun-Lai Shang, et al.
Published: (2018-07-01)

Suppressive effects of the Chinese herbal remedy Tripterygium wilfordii Hook f on eosinophilia and IgE hyperproduction in mice
by: Kazuhito Asano, et al.
Published: (2000-01-01)

Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy
by: Wei-Bo Le, et al.
Published: (2022-05-01)

Therapeutic Potential of Triptolide in Treating Bone-Related Disorders
by: Wu Gang, et al.
Published: (2022-06-01)

Cloning, Expression Analysis and Functional Characterization of Squalene Synthase (SQS) from Tripterygium wilfordii
by: Bin Zhang, et al.
Published: (2018-01-01)